Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia

OBJECTIVES: To evaluate the effectiveness of intravitreal bevacizumab (IVB) in patients with subretinal neovascularization secondary to type 2 juxtafoveal telangiectasia. MATERIALS AND METHODS: Ten eyes of 10 patients were included in this retrospective study. All cases were treated with IVB (1.25 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Baz, Ökkeş, Yılmaz, İhsan, Alagöz, Cengiz, Demircan, Ali, Perente, İrfan, Özkaya, Abdullah, Taşkapılı, Muhittin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468527/
https://www.ncbi.nlm.nih.gov/pubmed/28630789
http://dx.doi.org/10.4274/tjo.04874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468527/
https://www.ncbi.nlm.nih.gov/pubmed/28630789
http://dx.doi.org/10.4274/tjo.04874

Ejemplares similares